medline.ch Gynäkologie Mammae

	Timing matters: radiation necrosis risk of antibody-drug conjugates (ADCs) combined with radiation therapy in breast cancer brain metastases: a systematic review and comparative meta-analysis. Neurosurg Rev Zare A, Zare A, Kiani I, Delbari P, Mortezaei A, Ahmadvand MH, Rashidi F, Mohammadzadeh I, Azarmi E, Ghalehtaki R, Tafakhori A. PMID: 41748827 [PubMed - in process]
	Implant Pocket Plane Selection in Primary Breast Augmentation: A Meta-Analysis and Systematic Review of Complication Profiles. Aesthetic Plast Surg Alderhali R, Jamel WA, Dehnadi S, Seth I, Khajuria A. PMID: 41748776 [PubMed - as supplied by publisher]
	Breast Envelope Complications After Revision Breast Implant Surgery: A Systematic Review. Aesthetic Plast Surg Pagliara D, Grieco F, Schiavone L, Salgarello M, Rancati A. PMID: 41748774 [PubMed - as supplied by publisher]
	CMAF-Net: cross-modal attention fusion with information-theoretic regularization for imbalanced breast cancer histopathology. Sci Rep Ativi WX, Chen W, Kwao L, Ayivi W, Sam F, Alqahtani A, Gu YH, Al-Antari MA. PMID: 41748602 [PubMed - as supplied by publisher]
	No evidence for genotype-treatment interactions with breast cancer endocrine therapy adverse effects in UK Biobank. NPJ Breast Cancer Mokbel K, Weedon MN, Moye V, Ruth KS, Jackson L. PMID: 41748588 [PubMed - as supplied by publisher]
	Bayesian Indirect Comparison and Cost-Effectiveness of Sacituzumab Govitecan Versus Sacituzumab Tirumotecan in Metastatic Triple-Negative Breast Cancer. Value Health Shu Y, Tang Y, Ding Y, Zhang W, Zhang Q. PMID: 41747823 [PubMed - as supplied by publisher]
	Effect of a supervised intermittent exercise program on insomnia in breast cancer patients undergoing chemotherapy. Breast Cancer Res Treat Drozd C, Curtit E, Jacquinot Q, Roux P, Paget-Bailly S, Gillet V, Meneveau N, Mougin F. PMID: 41746533 [PubMed - in process]
	The impact of different pathological diagnostic criteria on the prognosis of malignant phyllodes tumors of the breast. Virchows Arch Cai L, Yue M, Shang J, Jia Y, Sun X, Liu C, Wang X, Wu S, Li J, Liu Y. PMID: 41746333 [PubMed - as supplied by publisher]
	Spatial Patterns of Breast Cancer Risk Associated with Industrial and Environmental Pollutants: A Scoping Review. Toxics Nahal D, Hoffpauir A, Kinariwala K, Tetteh P, Orenge F, Patel A, Ghalib A, Northeim K. PMID: 41745813 [PubMed]
	Dynamic Contrast-Enhanced MRI Kinetic Curve-Driven Parametric Radiomics for Predicting Breast Cancer Molecular Subtypes: A Multicenter and Interpretable Study. Tomography Wang T, Gong J, Wang S, Sun S, Zhou J, Lin L, Zhang D, You C, Gu Y. PMID: 41745704 [PubMed - in process]
	Automated Radiological Report Generation from Breast Ultrasound Images Using Vision and Language Transformers. J Imaging Khatoon S, Mahmood A. PMID: 41745433 [PubMed]
	Reproductive Toxicity of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer: A Case Report with a Literature Review. Diseases Tanase-Damian C, Antone NZ, Paun DL, Tanase I, Achima. PMID: 41745089 [PubMed]
	Metabolic Vulnerabilities as a Therapeutic Target in Breast Cancer. Curr Oncol Guo S, Addison CL. PMID: 41744893 [PubMed - in process]
	Estrogen Receptor-Low Positive (ER-Low) Breast Cancer: A Unique Clinical and Pathological Entity. Curr Oncol Faa G, Lai E, Ziranu P, Pretta A, Tiwari E, Dessì M, Solinas C, Saba G, Loi F, Codipietro C, Graziano S, Ottelio L, Dessena M, Coghe F, Suri JS, Saba L, Scartozzi M. PMID: 41744886 [PubMed - in process]
	Romanian Consensus Statement for Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer (HR+/HER2- mBC) and Triple-Negative Metastatic Breast Cancer (mTNBC). Curr Oncol Median MD, Antone NZ, Volov, Mazilu L, Negru , Curc, Ni, P, Ungureanu A, Lupu V, Oprean CM. PMID: 41744884 [PubMed - in process]
	Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Early Breast Cancer 2025. Curr Oncol Sehdev S, Joy AA, Boileau JF, Bouganim N, Brezden-Masley C, Cao JQ, Cescon DW, Chia S, Edwards S, Gelmon KA, Jerzak KJ, Kumar A, Laing K, LeVasseur N, Simmons C, Webster M, Manna M, On Behalf Of Patient Advocacy Breast Cancer Canada. PMID: 41744876 [PubMed - in process]
	Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Metastatic Breast Cancer 2025. Curr Oncol Jerzak KJ, Kumar A, Boileau JF, Bouganim N, Brezden-Masley C, Cao JQ, Cescon DW, Chia S, Edwards S, Joy AA, Laing K, LeVasseur N, Lupichuk S, Sehdev S, Simmons C, Webster M, Gelmon KA, Manna M, On Behalf Of Patient Advocacy Breast Cancer Canada. PMID: 41744870 [PubMed - in process]
	Trop2-Based Antibody-Drug Conjugates: Emerging Strategy and Progress in Triple-Negative Breast Cancer Therapy. Curr Oncol Li T, Zhang T, Dang Y, Lin Y, Li X, Ling X. PMID: 41744856 [PubMed - in process]
	DUSP1: Triple-Negative Breast Cancer and Therapeutic Potential. Curr Oncol Niture S, Thotala D, Jaboin J, Seneviratne D. PMID: 41744846 [PubMed - in process]
	Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2- Women with Metastatic Breast Cancer: Results from PALCAN Study. Curr Oncol Rayson D, Bertin J, Lemelin M, Tong M, Ng R, Ding P, Cheung WY, Sharma A, On PV, Feugère G, Lupichuk S. PMID: 41744845 [PubMed - in process]

Artikel 1 - 20 / 214977

Seite 1 von 10749

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung